Stay updated on APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial
Sign up to get notified when there's something new on the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page.

Latest updates to the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page
- Check2 days agoChange DetectedThe page’s UI/version label was updated from Revision v3.5.2 to v3.5.3 on the bottom of the ClinicalTrials.gov record, without any changes to the underlying study details.SummaryDifference0.0%

- Check9 days agoChange DetectedAdded Revision: v3.5.2. Deleted Revision: v3.5.0.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedTwo additional MeSH terms related to glomerulonephritis were added to the Additional Relevant MeSH Terms section, potentially improving searchability.SummaryDifference0.1%

- Check38 days agoChange DetectedRevision: v3.5.0 was added, replacing the previous Revision: v3.4.3.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision: v3.4.2 was added, and notices about government funding lapse and operating status were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check81 days agoChange DetectedA government funding notice banner is displayed on the page, informing visitors of potential delays and status updates. The revision tag has been updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

Stay in the know with updates to APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page.